Cargando…

Stem Cells as In Vitro Model of Parkinson's Disease

Progress in understanding neurodegenerative cell biology in Parkinson's disease (PD) has been hampered by a lack of predictive and relevant cellular models. In addition, the lack of an adequate in vitro human neuron cell-based model has been an obstacle for the uncover of new drugs for treating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Morales, Patricia L., Liste, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350852/ https://www.ncbi.nlm.nih.gov/pubmed/22619684 http://dx.doi.org/10.1155/2012/980941

Ejemplares similares

Physiological and pathological effects of amyloid-β species in neural stem cell biology
por: Bernabeu-Zornoza, Adela, et al.
Publicado: (2019)

Stem cell therapy for Parkinson’s disease: safety and modeling
por: Stoddard-Bennett, Theo, et al.
Publicado: (2019)

Physiological effects of amyloid precursor protein and its derivatives on neural stem cell biology and signaling pathways involved
por: Coronel, Raquel, et al.
Publicado: (2019)

Using induced pluripotent stem cells for modeling Parkinson’s disease
por: Ke, Minjing, et al.
Publicado: (2019)

The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease
por: Kang, Ji-feng, et al.
Publicado: (2016)

Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
por: Hu, Xinchao, et al.
Publicado: (2020)

Amyloid Precursor Protein (APP) Regulates Gliogenesis and Neurogenesis of Human Neural Stem Cells by Several Signaling Pathways
por: Coronel, Raquel, et al.
Publicado: (2023)

Impact of environmental neurotoxic: current methods and usefulness of human stem cells
por: Rosca, Andreea, et al.
Publicado: (2020)

Tyrosinase-Expressing Neuronal Cell Line as in Vitro Model of Parkinson’s Disease
por: Hasegawa, Takafumi
Publicado: (2010)

Low Levels of Amyloid Precursor Protein (APP) Promote Neurogenesis and Decrease Gliogenesis in Human Neural Stem Cells
por: Coronel, Raquel, et al.
Publicado: (2023)

Oligomeric and Fibrillar Species of Aβ42 Diversely Affect Human Neural Stem Cells
por: Bernabeu-Zornoza, Adela, et al.
Publicado: (2021)

Stem cell transplantation therapy in Parkinson’s disease
por: Fu, Mu-Hui, et al.
Publicado: (2015)

Stem Cell-Based Therapies for Parkinson Disease
por: Liu, Zhaohui, et al.
Publicado: (2020)

Neurogenesis Is Increased in Human Neural Stem Cells by Aβ40 Peptide
por: Bernabeu-Zornoza, Adela, et al.
Publicado: (2022)

Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
por: Li, Hong, et al.
Publicado: (2018)

Stem cell therapy for Parkinson’s disease using non-human primate models
por: Chen, Zhen-Zhen, et al.
Publicado: (2019)

Pluripotent stem cells for Parkinson's disease: progress and challenges
por: Zeng, Xianmin, et al.
Publicado: (2013)

Development of stem cell-based therapy for Parkinson’s disease
por: Han, Fabin, et al.
Publicado: (2015)

Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells
por: Mishima, Takayasu, et al.
Publicado: (2018)

Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease
por: Kim, Jeffrey, et al.
Publicado: (2022)

Cell therapy for Parkinson’s disease with induced pluripotent stem cells
por: Morizane, Asuka
Publicado: (2023)

Stem cell-based approach for the treatment of Parkinson's disease
por: Goodarzi, Parisa, et al.
Publicado: (2015)

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
por: Kouroupi, Georgia, et al.
Publicado: (2020)

Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
por: Coccia, Elena, et al.
Publicado: (2021)

Progress on stem cell research towards the treatment of Parkinson's disease
por: Gibson, Stuart AJ, et al.
Publicado: (2012)

Induced Pluripotent Stem Cells for Treatment of Alzheimer’s and Parkinson’s Diseases
por: Yefroyev, David A, et al.
Publicado: (2022)

Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
por: Gordon, Jonah, et al.
Publicado: (2022)

Stem cells and Parkinson's disease
Publicado: (2012)

Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease
por: Chou, Chung-Hsing, et al.
Publicado: (2015)

The Preclinical Research Progress of Stem Cells Therapy in Parkinson's Disease
por: Zhang, Jun, et al.
Publicado: (2016)

Parkinson's Disease and Mesenchymal Stem Cells: Potential for Cell-Based Therapy
por: Kitada, Masaaki, et al.
Publicado: (2012)

Reelin Alleviates Mesenchymal Stem Cell Senescence and Reduces Pathological α-Synuclein Expression in an In Vitro Model of Parkinson’s Disease
por: Cho, Eunju, et al.
Publicado: (2021)

Stem Cells as In Vitro Models of Disease
por: Dottori, Mirella, et al.
Publicado: (2012)

Stem cell models as an in vitro model for predictive toxicology
por: Lynch, Stephen, et al.
Publicado: (2019)

Potential sources of stem cells as a regenerative therapy for Parkinson’s disease
por: El-Sadik, Abir Oueida
Publicado: (2010)

Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
por: d’Angelo, Michele, et al.
Publicado: (2020)

The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment
por: Heris, Reza Mosaddeghi, et al.
Publicado: (2022)

CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
por: Pinjala, Poojitha, et al.
Publicado: (2023)

Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
por: Byers, Blake, et al.
Publicado: (2012)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_scg3nbtdbnki8rqgroip82s415